• Akebia Therapeutics (NASDAQ:AKBA) Receives "Buy" Rating from HC Wainwright

    Source: Buzz FX / 14 Jan 2025 11:31:17   America/Chicago


    Akebia Therapeutics (NASDAQ:AKBA) Receives "Buy" Rating from HC Wainwright Written by MarketBeat January 14, 2025 Share Link copied to clipboard. Akebia Therapeutics ( NASDAQ:AKBA - Get Free Report ) 's stock had its "buy" rating reissued b
    Read more...
Share on,